维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

12篇 您的检索式：作者名="Boccato"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre 显示文摘	A1-Chalabi T Boccato S Portmarm BC et M	2006	J Hepatol2006，45，4：	1
	2	Acquired my- eloperoxidase deficiency of neutrophils in a patient with aplastic anemia (idiopathic marrow aplasia) 显示文摘	Bizzaro N Briani G Boccato P	1988	Acta Haematol1988，80，2：	1
	3	Autoimmune hepatitis (AIH) in the elderly: A systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre显示文摘	Thawab Al-Chalabi Sylvia Boccato Bernard C. Portmann Ian G. McFarlane Michael A. Heneghan	2006	Journal of Hepatology2006，，4：	1
	4	Natural history of compensated viral cirrhosis:a prospective study on the incidence and hierarchy of major complications显示文摘	Benvegnu L Gios M Boccato S	2004	Gut2004，53，：	1
	5	Fibrosis progression in initially mild chronic hepatitis C显示文摘	Boccato S Pistis R Noventa F	2006	J Viral Hepat2006，13，5：	1
	6	Interferon β-1a alone or in combination with ribavirin: A randomized trial to compare efficacy and safety in chronic hepatitis C显示文摘AIM: To compare the efficacy and safety of recombinant human IFN β-1a alone or in combination with ribavirin in treatment-na(i)ve subjects with chronic hepatitis C.METHODS: Open, randomized trial was performed in 6 Italian tertiary centers: 102 of the 108 patients screened were randomized to receive 6 MIU of recombinant human IFN β-1a subcutaneously daily for 24 wk, alone (Group 1, n = 51) or in combination with ribavirin 1 000 to 1 200 mg/d (Group 2, n = 51).RESULTS: The end-of-treatment virologic response rate was 29.4% in Group 1 and 41.2% in Group 2 (non-significant). Twenty-four weeks after stopping therapy,sustained virologic response rate was 21.6% in Group 1 and 27.4% in Group 2 (non-significant). All subjects in Group 1 completed treatment, while two subjects in Group 2 stopped therapy due to treatment-related adverse events.CONCLUSION: Recombinant human IFN β-1a, alone or in combination with ribavirin, has an excellent safety profile and, may represent an alternative for chronic hepatitis C patients who are unable to tolerate pegylated α-interferon.	Rinaldo Pellicano Antonio Craxì Piero Luigi Almasio Mario Valenza Giovanna Venezia Alfredo Alberti Silvia Boccato Luigi Demelia Orazio Sorbello Antonino Picciotto Francesco Torre Gaetano Ideo Carlo Cattaneo Mara Berrutti Mario Rizzetto	2005	World Journal of Gastroenterology2005，11，29：	1
	7	Natural history of compensated viral cirrhosis:a prospective study on incidence and hierarchy of major complications显示文摘	Benvegnu L Gios M Boccato S		0，，05：	1
	8	Kimura's disease of the intraparotid lymph nodes:Fine needle aspiration biopsy findings显示文摘	Mannara GM Rinaldo A	1999	ORL J Otorhinolaryngol Relat Spec1999，61，4：	1
	9	Hyalinizinng clear cell carcinoma of the oral cavity and of the parotid gland 显示文摘	O'Rinaldo A Mclaren K M Boccato P	1999	J Otorhinolaryngol Relat Spee1999，61，：	1
	10	Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre 显示文摘	A1-Chalabi T Boccato S Portmann BC	2006	J Hepatol2006，45，4：	1
	11	Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre显示文摘	Chalabi T Boccato S Portmann BC	2006	J Hepatol2006，45，4：	1
	12	Autoimmune hep-atitis (AIH) in the elderly a systematic retrospective analysis of alarge group of consecutive patients with definite AIH followed at atertiary referral centre显示文摘	Al - Chalabi T Boccato S Portmann BC	2006	J Hepatol2006，45，4：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费